{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:26:38Z","timestamp":1787667998111,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005378","name":"Hacettepe University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the prognostic and predictive value of metabolic and volumetric parameters obtained from baseline (PET1) and post-chemotherapy (PET2) 18\u00a0F-FDG PET\/CT in pediatric Ewing sarcoma (EWS) patients, focusing on their associations with histopathologic response, metastatic presentation, overall survival (OS), and progression-free survival (PFS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective single tertiary academic center study included 55 pediatric EWS patients who underwent PET1. Twenty-four patients also had PET2. SUVmax, SUVpeak, metabolic tumor volume (MTV), total lesion glycolysis (TLG) and their percentage changes (\u2206) between PET scans were calculated using absolute (SUV 2.0 and 2.5) and relative (40% and 45%) thresholds. Anatomic tumor volume was also measured. Histopathologic evaluation was available for 40 patients with PET1 and 18 patients with PET2. Associations were analyzed using logistic and Cox regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline metabolic and volumetric PET parameters were significantly higher in patients with presenting metastasis. Among these, TLG (45%) was identified as the only independent predictor of metastatic presentation (OR\u2009=\u20091.026,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.019). Baseline MTV (2.0) was independently associated with shorter OS (HR\u2009=\u20091.026,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003) and PFS (HR\u2009=\u20091.035,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.038). Combined stratification using MTV (2.0) and histologic response revealed that patients with an unfavorable histologic response but low MTV demonstrated superior OS and PFS rates than those with an unfavorable response and high MTV. The survival outcomes of patients with a favorable histologic response and high MTV were comparable to those with an unfavorable response and low MTV. However, PET parameters did not reliably predict histopathologic response in this cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Baseline MTV (2.0) demonstrated prognostic value for OS and PFS, while TLG (45%) independently predicted metastatic presentation in pediatric EWS. The combination of MTV (2.0) and histologic response appears to provide complementary prognostic information. Prospective, multicenter studies with standardized imaging and treatment protocols are warranted to validate the role of volumetric 18\u00a0F-FDG PET parameters in clinical risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12149-026-02229-6","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:41:46Z","timestamp":1779334906000},"page":"1121-1130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["18\u00a0F-FDG PET\/CT Derived Volumetric Parameters Can Predict Outcome in Pediatric Ewing Sarcoma"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-751X","authenticated-orcid":false,"given":"Ba\u015fak","family":"Soyda\u015f-Turan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilge","family":"Volkan-Salanc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bur\u00e7a","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0131nar","family":"Kiratli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"2229_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/CCO.0b013e328303ba1d","volume":"20","author":"JA Ludwig","year":"2008","unstructured":"Ludwig JA. Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future. Curr Opin Oncol. 2008;20:412\u20138.","journal-title":"Curr Opin Oncol"},{"key":"2229_CR2","doi-asserted-by":"publisher","first-page":"11000","DOI":"10.1038\/s41598-019-46721-8","volume":"9","author":"SE Bosma","year":"2019","unstructured":"Bosma SE, Lancia C, Rueten-Budde AJ, Ranft A, Gelderblom H, Fiocco M, et al. Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgery. Sci Rep. 2019;9:11000.","journal-title":"Sci Rep"},{"key":"2229_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/cncr.22821","volume":"110","author":"C Rodr\u00edguez-Galindo","year":"2007","unstructured":"Rodr\u00edguez-Galindo C, Liu T, Krasin MJ, Wu J, Billups CA, Daw NC, et al. Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children\u2019s Research Hospital studies. Cancer. 2007;110:375\u201384.","journal-title":"Cancer"},{"key":"2229_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/metabo12030217","volume":"12","author":"V Lyra","year":"2022","unstructured":"Lyra V, Chatziioannou S, Kallergi M. Clinical perspectives for (18)F-FDG PET imaging in pediatric oncology: metabolic tumor volume and radiomics. Metabolites. 2022;12:217.","journal-title":"Metabolites"},{"key":"2229_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/cncr.22412","volume":"109","author":"PP Lin","year":"2007","unstructured":"Lin PP, Jaffe N, Herzog CE, Costelloe CM, Deavers MT, Kelly JS, et al. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma. Cancer. 2007;109:603\u201311.","journal-title":"Cancer"},{"key":"2229_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/1754-9485.12389","volume":"60","author":"MS Ning","year":"2016","unstructured":"Ning MS, Perkins SM, Borinstein SC, Holt GE, Stavas MJ, Shinohara ET. Role of radiation in the treatment of non-metastatic osseous Ewing sarcoma. J Med Imaging Radiat Oncol. 2016;60:119\u201328.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2229_CR7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/pbc.24406","volume":"60","author":"EN Newman","year":"2013","unstructured":"Newman EN, Jones RL, Hawkins DS. An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration\/biopsy as staging investigations in Ewing sarcoma. Pediatr Blood Cancer. 2013;60:1113\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"2229_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/MPH.0000000000001135","volume":"40","author":"A Ruggiero","year":"2018","unstructured":"Ruggiero A, Lanni V, Librizzi A, Maurizi P, Attin\u00e0 G, Mastrangelo S, et al. Diagnostic accuracy of 18F-FDG PET\/CT in the staging and assessment of response to chemotherapy in children with Ewing sarcoma. J Pediatr Hematol Oncol. 2018;40:277\u201384.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2229_CR9","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s00259-013-2388-9","volume":"40","author":"P Sharma","year":"2013","unstructured":"Sharma P, Khangembam BC, Suman KC, Singh H, Rastogi S, Khan SA, et al. Diagnostic accuracy of 18F-FDG PET\/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma. Eur J Nucl Med Mol Imaging. 2013;40:1036\u201343.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2229_CR10","doi-asserted-by":"publisher","first-page":"7012","DOI":"10.1007\/s00330-021-07841-w","volume":"31","author":"A Annovazzi","year":"2021","unstructured":"Annovazzi A, Ferraresi V, Anelli V, Covello R, Vari S, Zoccali C, et al. [(18)F]FDG PET\/CT quantitative parameters for the prediction of histological response to induction chemotherapy and clinical outcome in patients with localised bone and soft-tissue Ewing sarcoma. Eur Radiol. 2021;31:7012\u201321.","journal-title":"Eur Radiol"},{"key":"2229_CR11","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1200\/JCO.2005.01.7079","volume":"23","author":"DS Hawkins","year":"2005","unstructured":"Hawkins DS, Schuetze SM, Butrynski JE, Rajendran JG, Vernon CB, Conrad III EU, et al. [18F] Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol. 2005;23:8828\u201334.","journal-title":"J Clin Oncol"},{"key":"2229_CR12","doi-asserted-by":"publisher","first-page":"e0153281","DOI":"10.1371\/journal.pone.0153281","volume":"11","author":"JP Hwang","year":"2016","unstructured":"Hwang JP, Lim I, Kong C-B, Jeon DG, Byun BH, Kim BI, et al. Prognostic value of SUVmax measured by pretreatment fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography in patients with Ewing sarcoma. PLoS ONE. 2016;11:e0153281.","journal-title":"PLoS ONE"},{"key":"2229_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00259-016-3509-z","volume":"44","author":"E Palmerini","year":"2017","unstructured":"Palmerini E, Colangeli M, Nanni C, Fanti S, Marchesi E, Paioli A, et al. The role of FDG PET\/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas. Eur J Nucl Med Mol Imaging. 2017;44:215\u201323.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2229_CR14","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.7150\/jca.20077","volume":"8","author":"U Salem","year":"2017","unstructured":"Salem U, Amini B, Chuang HH, Daw NC, Wei W, Haygood TM, et al. 18F-FDG PET\/CT as an indicator of survival in Ewing sarcoma of bone. J Cancer. 2017;8:2892\u201398.","journal-title":"J Cancer"},{"key":"2229_CR15","doi-asserted-by":"publisher","first-page":"e0183841","DOI":"10.1371\/journal.pone.0183841","volume":"12","author":"C Bailly","year":"2017","unstructured":"Bailly C, Leforestier R, Campion L, Thebaud E, Moreau A, Kraeber-Bodere F, et al. Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma. PLoS ONE. 2017;12:e0183841.","journal-title":"PLoS ONE"},{"key":"2229_CR16","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1097\/MPH.0000000000001518","volume":"42","author":"D Albano","year":"2020","unstructured":"Albano D, Dondi F, Schumacher RF, D\u2019Ippolito C, Porta F, Giubbini R, et al. Clinical and prognostic role of 18F-FDG PET\/CT in pediatric Ewing sarcoma. J Pediatr Hematol Oncol. 2020;42:e79\u201386.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2229_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00259-011-1936-4","volume":"39","author":"HJ Im","year":"2012","unstructured":"Im HJ, Kim TS, Park S-Y, Min HS, Kim JH, Kang HG, et al. Prediction of tumour necrosis fractions using metabolic and volumetric 18 F-FDG PET\/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma. Eur J Nucl Med Mol Imaging. 2012;39:39\u201349.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2229_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1148\/radiol.2017162758","volume":"287","author":"H-J Im","year":"2018","unstructured":"Im H-J, Zhang Y, Wu H, Wu J, Daw NC, Navid F, et al. Prognostic value of metabolic and volumetric parameters of FDG PET in pediatric osteosarcoma: a hypothesis-generating study. Radiology. 2018;287:303\u201312.","journal-title":"Radiology"},{"key":"2229_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/230949900801600211","volume":"16","author":"I Munajat","year":"2008","unstructured":"Munajat I, Zulmi W, Norazman M, Faisham WW. Tumour volume and lung metastasis in patients with osteosarcoma. J Orthop Surg. 2008;16:182\u20135.","journal-title":"J Orthop Surg"},{"key":"2229_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12094-015-1351-6","volume":"18","author":"A Raciborska","year":"2016","unstructured":"Raciborska A, Bilska K, Drabko K, Michalak E, Chaber R, Pogorza\u0142a M, et al. Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma. Clin Transl Oncol. 2016;18:189\u201395.","journal-title":"Clin Transl Oncol"},{"key":"2229_CR21","doi-asserted-by":"publisher","first-page":"e28605","DOI":"10.1002\/pbc.28605","volume":"67","author":"G El-Hennawy","year":"2020","unstructured":"El-Hennawy G, Moustafa H, Omar W, Elkinaai N, Kamel A, Zaki I, et al. Different 18F\u2010FDG PET parameters for the prediction of histological response to neoadjuvant chemotherapy in pediatric Ewing sarcoma family of tumors. Pediatr Blood Cancer. 2020;67:e28605.","journal-title":"Pediatr Blood Cancer"},{"key":"2229_CR22","first-page":"869","volume":"11","author":"RI Hack","year":"2021","unstructured":"Hack RI, Becker AS, Bode-Lesniewska B, Exner GU, M\u00fcller DA, Ferraro DA, et al. When SUV matters: FDG PET\/CT at baseline correlates with survival in soft tissue and Ewing sarcoma. Life (Basel). 2021;11:869.","journal-title":"Life (Basel)"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02229-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02229-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02229-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:43:38Z","timestamp":1787665418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02229-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2229"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02229-6","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}